Cargando…
The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs hav...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116184/ https://www.ncbi.nlm.nih.gov/pubmed/30061485 http://dx.doi.org/10.3390/cancers10080251 |
_version_ | 1783351547610005504 |
---|---|
author | Savant, Sudha S. Sriramkumar, Shruthi O’Hagan, Heather M. |
author_facet | Savant, Sudha S. Sriramkumar, Shruthi O’Hagan, Heather M. |
author_sort | Savant, Sudha S. |
collection | PubMed |
description | Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC. |
format | Online Article Text |
id | pubmed-6116184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61161842018-08-31 The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer Savant, Sudha S. Sriramkumar, Shruthi O’Hagan, Heather M. Cancers (Basel) Review Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC. MDPI 2018-07-30 /pmc/articles/PMC6116184/ /pubmed/30061485 http://dx.doi.org/10.3390/cancers10080251 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Savant, Sudha S. Sriramkumar, Shruthi O’Hagan, Heather M. The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
title | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
title_full | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
title_fullStr | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
title_full_unstemmed | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
title_short | The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer |
title_sort | role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116184/ https://www.ncbi.nlm.nih.gov/pubmed/30061485 http://dx.doi.org/10.3390/cancers10080251 |
work_keys_str_mv | AT savantsudhas theroleofinflammationandinflammatorymediatorsinthedevelopmentprogressionmetastasisandchemoresistanceofepithelialovariancancer AT sriramkumarshruthi theroleofinflammationandinflammatorymediatorsinthedevelopmentprogressionmetastasisandchemoresistanceofepithelialovariancancer AT ohaganheatherm theroleofinflammationandinflammatorymediatorsinthedevelopmentprogressionmetastasisandchemoresistanceofepithelialovariancancer AT savantsudhas roleofinflammationandinflammatorymediatorsinthedevelopmentprogressionmetastasisandchemoresistanceofepithelialovariancancer AT sriramkumarshruthi roleofinflammationandinflammatorymediatorsinthedevelopmentprogressionmetastasisandchemoresistanceofepithelialovariancancer AT ohaganheatherm roleofinflammationandinflammatorymediatorsinthedevelopmentprogressionmetastasisandchemoresistanceofepithelialovariancancer |